969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

Current Study Opportunities at The CRC

Studies at CRC can change frequently.  For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 6-14-21.

Study #1 : An investigational research study of a once daily investigational tablet versus placebo for people with chronic, unexplained cough (at least 10 times in one hour)

Brief description of study

This investigational research study has 8 visits. Visits will be 2-3 hours each. Appointments may be made Monday through Saturday mornings. Patients must be relatively healthy other than unexplained chronic cough (at least 10 times in an hour). Must not have chronic bronchitis, COPD or uncontrolled asthma. Patient must be non smoker with little to no previous smoke histroy.

Pleae fill out Volunteer Questionnaire or contact Monica Shutz at 314-514-8509 ext 12

Clinical Study Identifier: TX228637

Study #2 : An asthma research study assessing safety and efficacy of an inhaled once daily medication when added to patients already using maintenance inhalers. All subjects are switched to Advair 250 or 500 during the trial.

Brief description of study

This study has 11-12 visits and can be completed in 7 months. Subjects must be using maintenance inhalers and have had an asthma flare requiring Prednisone within the last 12 months. 

Detailed Study Description

Visits must be done in the morning and can be scheduled Monday-Saturday. Patients must be between 18-75 years of age and currently treating asthma with certain inhaled medications. Compensation for participation may be provided for those who qualify.

Please contact Monica at 314-514-8509 extension 12 or email generalmailbox@clinicalresearchcenter.com to learn more

Clinical Study Identifier: TX228576

Study #3 : COPD Study enrolling for those using rescue inhaler as needed or using daily maintenance inhalers.

Brief description of study

This study is testing the safety and efficacy of a nebulized investigational medication for the treatment of COPD.

This study has either 6 visits over 28 weeks or 10 visits over 52 weeks. Study related pulmonary function testing, chest x ray, lab work, ECG’s and physical exams are included at no cost and compensation for participation may be provided.

Detailed Study Description

This study requires morning appointments. We are available Monday-Saturday. Compensation for participation may be provided to those who qualify.

Please contact Monica at 314-514-8509 extension 12 or email generalmailbox@clinicalresearchcenter.com to learn more details.

Study #4 : Moderate to Severe Asthma Research Study for those currently using medium to high dose controller medication for at least 3 months and have required an oral steroid for a flare in breathing at least once in the last 12 months.

Brief description of study

This investigational research study is enrolling moderate to severe asthmatics.

To qualify you must be on inhaled maintenance medications and have required oral steroids at least once in the last year, for asthma. The study consists of 17 visits over approximately 7-8 months. Subjects will remain on current asthma controllers. The study medication is an injectable investigational medication and will be given every 2 weeks. 

Pulmonary function test will be performed and compensation will be provided for those who qualify. Please contact Monica at 314-514-8509 ext 12 or email recruitment@clinicalresearchcenter.com

Clinical Study Identifier: TX228636

Study #5 : Chronic Hives Research Study to evaluate investigational study medication by self injection at home

 Brief description of study

The Clinical Research Center in West St. Louis County is conducting a research study of an investigational medication, given by self injection at home, to evaluate the safety and effectiveness in subjects who suffer with chronic hives. This study consists of 5 clinic visits and the study will be approximately 40 weeks long. Qualified patients will be previous omalizumab non responders. Hives must be present for the last 6 weeks despite treatment with an H1 antihistamine. 

Please contact Monica at 314-514-8509, extension 12 or email recruitment@clinicalresearchcenter.com

Clinical Study Identifier: TX202119

Study #6 : Asthma Study for investigational injectable medication when added to patients already on standard of care inhaled medications.

Brief description of study

This study requires 14 visits over approximately 30 weeks. Visit are in mornings and are approximately every 2 weeks.

Detailed Study Description

Subjects must have physician diagnosed asthma and currently treating with medium to high dose inhaled medications and have at least one documented flare in breathing that required Prednisone within the last 18 months.

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call Monica at 314-514-8509 ext 12 for more details.

 

Contact CRC
By acknowledging or signing the agreement, the customer is authorizing The Clinical Research Center to periodically send text message updates about current or future studies that may be of interest. The Clinical Research Center will send occasional texts pertaining to studies that may be of interest to you or studies that you are enrolled in. You can opt-out at any time. Text and data rates may apply. Privacy Policy.